Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2018
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD studyE Aranda, P García-Alfonso, M Benavides, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Safety and efficacy of encorafenib-cetuximab combination in <i>BRAF</i> <sup><i>V600E</i></sup> -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter studyA Fernández-Montes, J Ros, P García-Alfonso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antiviralsMaría Sánchez-Azofra, Inmaculada Fernández, María L García-Buey, et al.
Melanoma Research|March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational studyJosé L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Revista Clinica Espanola|August 9, 2020
Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 RegistryJ M Casas-Rojo, J M Antón-Santos, J Millán-Núñez-Cortés, et al.
Revista Clinica Espanola|May 17, 2021
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry]J M Casas-Rojo, J M Antón-Santos, J Millán-Núñez-Cortés, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
Science (New York, N.Y.)|March 30, 2023
Early dispersal of domestic horses into the Great Plains and northern RockiesWilliam Timothy Treal Taylor, Pablo Librado, Chief Joseph American Horse, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2018
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD studyE Aranda, P García-Alfonso, M Benavides, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Safety and efficacy of encorafenib-cetuximab combination in <i>BRAF</i> <sup><i>V600E</i></sup> -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter studyA Fernández-Montes, J Ros, P García-Alfonso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antiviralsMaría Sánchez-Azofra, Inmaculada Fernández, María L García-Buey, et al.
Melanoma Research|March 29, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational studyJosé L Manzano, Juan Martin-Liberal, Luis A Fernández-Morales, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Revista Clinica Espanola|August 9, 2020
Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 RegistryJ M Casas-Rojo, J M Antón-Santos, J Millán-Núñez-Cortés, et al.
Revista Clinica Espanola|May 17, 2021
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry]J M Casas-Rojo, J M Antón-Santos, J Millán-Núñez-Cortés, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
Science (New York, N.Y.)|March 30, 2023
Early dispersal of domestic horses into the Great Plains and northern RockiesWilliam Timothy Treal Taylor, Pablo Librado, Chief Joseph American Horse, et al.
Pageof 18